MLLT3 Human Pre-designed siRNA Set A contains three designed siRNAs for MLLT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MLLT6 Human Pre-designed siRNA Set A contains three designed siRNAs for MLLT6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MLN Human Pre-designed siRNA Set A contains three designed siRNAs for MLN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MLNR Human Pre-designed siRNA Set A contains three designed siRNAs for MLNR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mlnr Rat Pre-designed siRNA Set A contains three designed siRNAs for Mlnr gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MLPH Human Pre-designed siRNA Set A contains three designed siRNAs for MLPH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MLST8 Human Pre-designed siRNA Set A contains three designed siRNAs for MLST8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MLX Human Pre-designed siRNA Set A contains three designed siRNAs for MLX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MLXIP Human Pre-designed siRNA Set A contains three designed siRNAs for MLXIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MLXIPL Human Pre-designed siRNA Set A contains three designed siRNAs for MLXIPL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MLYCD Human Pre-designed siRNA Set A contains three designed siRNAs for MLYCD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMA-NODAGA is a chelator for site-specific labeling of targeting proteins containing unpaired cysteine. MMA-NODAGA can be used to conjugate with exosome and 64Cu in image with positron emission tomography (PET)[1]

MMAA Human Pre-designed siRNA Set A contains three designed siRNAs for MMAA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMAB Human Pre-designed siRNA Set A contains three designed siRNAs for MMAB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMACHC Human Pre-designed siRNA Set A contains three designed siRNAs for MMACHC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMADHC Human Pre-designed siRNA Set A contains three designed siRNAs for MMADHC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMAF-OtBu (Example 2) is a modified MMAF (HY-15579 ). MMAF-OtBu can be used for synthesis of ADCs[1].

MMAF-OtBu (Example 2) is a modified MMAF (HY-15579 ). MMAF-OtBu can be used for synthesis of ADCs[1].

MMAF-OtBu (Example 2) is a modified MMAF (HY-15579 ). MMAF-OtBu can be used for synthesis of ADCs[1].

MMAF-OtBu (Example 2) is a modified MMAF (HY-15579 ). MMAF-OtBu can be used for synthesis of ADCs[1].

MMAF-OtBu (Example 2) is a modified MMAF (HY-15579 ). MMAF-OtBu can be used for synthesis of ADCs[1].

MMAI is a selective serotonin releaser that can be used in the research of mental illnesses[1].

MMBC is a sulfhydryl-sensitive fluorophore[1].

MMC(TMZ)-TOC has high binding affinity and selectivity for somatostatin receptor subtype-2 (SSTR2). MMC(TMZ)-TOC targets delivery of TMZ to SSTR2-positive tumor cells[1].

MMD Human Pre-designed siRNA Set A contains three designed siRNAs for MMD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMD2 Human Pre-designed siRNA Set A contains three designed siRNAs for MMD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MME Human Pre-designed siRNA Set A contains three designed siRNAs for MME gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMEL1 Human Pre-designed siRNA Set A contains three designed siRNAs for MMEL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMG-0358 is a potent IDO1 inhibitor. MMG-0358 shows IC50 values of 2 nM in a cellular assay on mIDO1, 80 nM in a cellular assay on hIDO1, 330 nM in an enzymatic assay on hIDO1 at pH 6.5, and 71 nM in an enzymatic assay on hIDO1 at pH 7.4[1].

MMGT1 Human Pre-designed siRNA Set A contains three designed siRNAs for MMGT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMP-9-IN-9 (compound 4f) is a slective MMP-9 inhibitor with an IC50 of 5 nM. MMP-9-IN-9 shows selective for MMP-9 over MMP-1 and MMP-13. MMP-9-IN-9 shows strong anti-inflammatory and neuroprotective effects[1].

MMP-9/10-IN-1 (Compound 6b) is a potent dual MMP-9/10 Inhibotor with IC50s of 0.076 and 0.139 μM against NSCLC and A549 cells, respectively. MMP-9/10-IN-1 has anti-invasive and anti-angiogenic activities when in combination with Sorafenib (HY-10201) [1].

MMP-9/10-IN-2 (compound 6e) is a potent inhibitor of MMP10 and MMP9, with IC50 of 0.076 μM for MMP10, and 93.18% inhibition at 0.5 μM for MMP9. MMP-9/10-IN-2 plays an important role in anti-tumor[1].

MMP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MMP1. It can be used for WB,FC,ICC/IF,IHC-P assays with tag free, in the background of Human.

MMP1 Human Pre-designed siRNA Set A contains three designed siRNAs for MMP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mmp1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Mmp1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMP10 Human Pre-designed siRNA Set A contains three designed siRNAs for MMP10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mmp10 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mmp10 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mmp10 Rat Pre-designed siRNA Set A contains three designed siRNAs for Mmp10 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMP11 Human Pre-designed siRNA Set A contains three designed siRNAs for MMP11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMP12 Human Pre-designed siRNA Set A contains three designed siRNAs for MMP12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mmp12 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mmp12 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mmp12 Rat Pre-designed siRNA Set A contains three designed siRNAs for Mmp12 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MMP12-IN-3 (compound 32) is a potent MMP12 inhibitor with an IC50 value of 4.9 nM. MMP12-IN-3 has the potential for the research of chronic respiratory diseases such as emphysema[1].

MMP13 Human Pre-designed siRNA Set A contains three designed siRNAs for MMP13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.